Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Intellipharmaceutics (IPCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,856
  • Shares Outstanding, K 31,070
  • Annual Sales, $ 2,250 K
  • Annual Income, $ -10,140 K
  • 36-Month Beta 0.99
  • Price/Sales 5.90
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.35
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/09/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.74 +28.38%
on 12/27/17
1.05 -9.52%
on 01/19/18
+0.20 (+26.67%)
since 12/19/17
3-Month
0.70 +35.71%
on 12/13/17
1.05 -9.52%
on 01/19/18
-0.05 (-5.00%)
since 10/19/17
52-Week
0.70 +35.71%
on 12/13/17
3.12 -69.55%
on 02/03/17
-1.65 (-63.46%)
since 01/19/17

Most Recent Stories

More News
Toronto Exchanges Stock Review, Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / January 16, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Oncolytics Biotech, Aurinia...

AUP.TO : 6.97 (+1.90%)
IPCI.TO : 1.19 (+19.00%)
IMV.TO : 2.12 (-1.40%)
AUPH : 5.57 (+1.46%)
ONC.TO : 0.99 (+2.06%)
IPCI : 0.95 (+18.75%)
Canadian Exchanges Stock Scanner Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / December 14, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Oncolytics Biotech, Aurinia...

AUP.TO : 6.97 (+1.90%)
IPCI.TO : 1.19 (+19.00%)
IMV.TO : 2.12 (-1.40%)
AUPH : 5.57 (+1.46%)
ONC.TO : 0.99 (+2.06%)
IPCI : 0.95 (+18.75%)
Intellipharmaceutics Announces Receipt of Nasdaq Notice

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

IPCI.TO : 1.19 (+19.00%)
IPCI : 0.95 (+18.75%)
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR(R) by Par Pharmaceutical

Intellipharmaceutics International Inc. (NASDAQ:IPCI) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel...

IPCI.TO : 1.19 (+19.00%)
IPCI : 0.95 (+18.75%)
Daily Coverage on Healthcare Stocks, Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / November 8, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select...

AUP.TO : 6.97 (+1.90%)
IPCI.TO : 1.19 (+19.00%)
IMV.TO : 2.12 (-1.40%)
AUPH : 5.57 (+1.46%)
ONC.TO : 0.99 (+2.06%)
IPCI : 0.95 (+18.75%)
Corporate News Blog - Valeant Pharma Sells Sprout Pharma's Subsidiary Back to Original Shareholders

Research Desk Line-up: IntelliPharmaCeutics Intl. Post Earnings Coverage

VRX : 21.52 (-2.62%)
IPCI : 0.95 (+18.75%)
Intellipharmaceutics Announces Closing of US$4 Million Financing

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

IPCI.TO : 1.19 (+19.00%)
IPCI : 0.95 (+18.75%)
New Strong Sell Stocks for October 11th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BCRH : 12.80 (+0.79%)
FLS : 43.71 (-1.40%)
VRX : 21.52 (-2.62%)
IPCI : 0.95 (+18.75%)
PIRS : 7.42 (+0.68%)
Intellipharmaceutics Announces US$4 Million Registered Direct Offering

Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

IPCI.TO : 1.19 (+19.00%)
IPCI : 0.95 (+18.75%)
Intellipharmaceutics Announces Third Quarter 2017 Results

Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

IPCI.TO : 1.19 (+19.00%)
IPCI : 0.95 (+18.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More

Business Summary

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including...

See More

Key Turning Points

2nd Resistance Point 1.13
1st Resistance Point 1.04
Last Price 0.95
1st Support Level 0.87
2nd Support Level 0.79

See More

52-Week High 3.12
Fibonacci 61.8% 2.20
Fibonacci 50% 1.91
Fibonacci 38.2% 1.62
Last Price 0.95
52-Week Low 0.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.